A Phase 3 Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Efgartigimod PH20 SC in Adult Participants With Bullous Pemphigoid

PHASE3TerminatedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

March 22, 2023

Primary Completion Date

March 20, 2025

Study Completion Date

March 20, 2025

Conditions
Bullous Pemphigoid
Interventions
BIOLOGICAL

efgartigimod PH20 SC

Subcutaneous injection of efgartigimod coformulated with rHuPH20, a permeation enhancer

DRUG

Prednisone

Oral Prednisone

Trial Locations (40)

1085

Semmelweis Egyetem, Budapest

1431

Diagnostic and Consulting Center Aleksandrovska EOOD, Sofia

2217

Premier Specialists, Kogarah

10000

Poliklinika Solmed, Zagreb

10117

Charité - Universitätsmedizin Berlin, Berlin

11000

University Clinical Center of Serbia - PPDS, Belgrade

16121

Hospital of Venereal and Skin Diseases A.Syggros, Athens

16132

Ospedale Policlinico San Martino, Genova

18016

Hospital Universitario Clínico San Cecilio, Granada

20122

Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan

24105

Universitatsklinikum Schleswig-Holstein, Kiel

27100

Fondazione IRCCS Policlinico San Matteo di Pavia, Pavia

28041

Hospital Universitario 12 de Octubre, Madrid

33173

Miami Dermatology and Laser Institute, Miami

40225

Universitatsklinikum Dusseldorf, Düsseldorf

45324

Wright State Physicians, Fairborn

46017

Hospital Universitario Doctor Peset, Valencia

48109

University of Michigan Hospital, Ann Arbor

50122

Azienda USL Toscana Centro - Ospidale Piero Palagi, Florence

50125

Azienda Sanitaria Di Firenze, Florence

54643

Hospital Of Skin And Venereal Diseases of Thessaloniki, Thessaloniki

63110

Saint Louis University, St Louis

80337

LMU Klinikum der Universität, München

85006

Medical Dermatology Specialists, Phoenix

91702

Fakultna nemocnica Trnava, Trnava

92708

First OC Dermatology, Fountain Valley

95123

Azienda Ospedaliero Universitaria Policlinico Vittorio Emanuele, Catania

97080

Universitätsklinikum Würzburg, Würzburg

200025

Ruijin Hospital Shanghai Jiaotong University School of Medicine, Shanghai

400016

The First Affiliated Hospital of Chongqing Medical University, Chongqing

610041

West China Hospital of Sichuan University, Chengdu

5262100

Sheba Medical Center - PPDS, Ramat Gan

180 00

Fakultni nemocnice Bulovka, Prague

01307

Universitätsklinikum Carl Gustav Carus an der TU Dresden, Dresden

00167

IDI IRCCS - Istituto Dermopatico dell'Immacolata, Roma

00168

Fondazione Policlinico Universitario A. Gemelli, Rome

060-8648

Hokkaido University Hospital, Sapporo

9713 GZ

Universitair Medisch Centrum Groningen, Groningen

821 06

Univerzitna nemocnica Bratislava, Bratislava

SE1 9RT

Guy's and St Thomas' NHS Foundation Trust, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

argenx

INDUSTRY